Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $2750.0000 (0%) ($0.0000 - $0.0000) on Mon. Dec. 31, 2007. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 6% (three month average) | | RSI | 0 | | Latest Price | $2750.0000(0%) | | Stocks Behave Similarly | Similar Stock List | | Weekly Trend | CAPR declines -2.3% a week on average for past two weeks. | | Market Behavior | Normal for large cap. Normal for small cap. | | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability)
PEJ(3%) EWP(2%) IWM(2%) USO(2%) XOP(2%) | | Factors Impacting CAPR price | CAPR will decline at least -3% in a week (0% probabilities).
EWY(-1%) XLU(0%) XLP(0%) VWO(0%) TLT(0%) | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -3% (StdDev 6%) | | Hourly BBV | 0 () | | Intraday Trend | 0% | | | | | |
|
| Resistance Level | $2834.6 | | 5 Day Moving Average | $2750(0%) | | 10 Day Moving Average | $2796.7(-1.67%) | | 20 Day Moving Average | $2834.6(-2.98%) | | To recent high | -15.4% | | To recent low | 27.9% | | Market Cap | $54.168b | | | | | | |
Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |